Arrowhead Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$264,033
$256,472
$27,767
$542,709
Gross Profit
264,033
256,472
21,544
542,709
EBITDA
57,166
64,201
-148,484
397,339
EBIT
50,776
57,815
-154,707
391,255
Net Income
30,811
-23,750
-175,241
370,445
Net Change In Cash
264,033
256,472
27,767
542,709
Free Cash Flow
11,333
13,002
-157,084
454,756
Cash
201,643
226,548
129,793
185,709
Basic Shares
140,706
135,702
139,039
134,484

Annual Financials

Values in thousands2025-09-302024-09-302023-09-302022-09-30
Revenue
$829,448
$3,551
$240,735
$243,231
Gross Profit
805,520
3,551
240,735
243,231
EBITDA
164,822
-561,513
-175,672
-168,086
EBIT
140,894
-580,108
-188,165
-178,507
Net Income
-1,631
-599,493
-205,275
-176,494
Net Change In Cash
829,448
3,551
240,735
243,231
Cost of Revenue
-76,362
Free Cash Flow
156,886
-604,320
-330,627
-188,908
Cash
226,548
102,685
110,891
108,005
Basic Shares
133,758
119,784
106,750
105,426

Earnings Calls

QuarterEPS
2025-12-31
$0.22
2025-09-30
-$0.11
2025-06-30
-$1.26
2025-03-31
$2.75